MedCannAccess signed a letter of intent to acquire Buccaneer Gold Corp (TSXV:BGG) in a reverse merger transaction on July 17, 2014. Pursuant to the terms of the transaction, shareholders of MedCannAccess will receive one resulting issuer share for each outstanding share in MedCannAccess, representing approximately 93.49% of the issued and outstanding resulting issuer shares upon completion of the transaction, while shareholders of Buccaneer will receive one resulting issuer share for every twenty-three common shares in Buccaneer representing approximately 6.51% of the issued and outstanding resulting shares upon completion of the transaction. Upon completion of the transaction, the resulting company will continue to carry on the business of MedCannAccess as currently constituted. The business combination will result in Buccaneer adopting such name as is proposed by MedCannAccess to continue as the parent corporation of MedCannAccess, with the shares of the resulting company to be posted and listed for trading on the TSX Venture Exchange.

On completion of the transaction, the management team and Board of Directors of the resulting issuer is expected to include the persons identified below: Blaine Dowdle, Director and Chief Executive Officer; Kevin Furet, Vice-President, Production; Rade Kovacevic, Vice-President, Business Development; Scott Belton, Quality Assurance Manager, Plant Research and Development Manager; Theresa Kozak, Client Services Manager and Paul Zyla, Director. A duly qualified Chief Financial Officer will be appointed prior to completion of the transaction. As on January 23, 2015, Buccaneer and MedCannAccess continue working towards completion of their transaction.

The transaction is subject to regulatory approval, including the approval of the TSX-V and standard closing conditions, including the approval of the transaction by the Directors of each of Buccaneer and MedCannAccess, completion of due diligence investigations to the satisfaction of each of the parties, negotiation and execution of a definitive agreement, receipt of all requisite approvals from shareholders of MedCannAccess and Buccaneer, third parties (including lenders or financial institutions, licensors and strategic partners involved in the manufacturing, distribution and sale of MedCannAccess' products) relating to the transaction. Buccaneer Gold, 8437726 Canada Inc. and Richmond Capital agreed to extend the due diligence period by 15 days in order to permit Buccaneer to have additional time to complete its studies. They have extended to September 15, 2014. The time for entering into definitive agreement is August 31, 2014.

MedCannAccess cancelled the acquisition of Buccaneer Gold Corp (TSXV:BGG) in a reverse merger transaction on May 26, 2015.